Drug research alliance targets diseases of developing world

05/3/2005 | Los Angeles Times (tiered subscription model)

An alliance of drugmakers, philanthropists and governments are targeting neglected diseases such as malaria and tuberculosis that infect millions of people every year in low-income countries with little ability to pay for treatments. In addition to GlaxoSmithKline's Drugs for the Developing World center, AstraZeneca, Novartis and other drugmakers have joined several such alliances.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT